There are 15,356 results relating to "Medicin Viagra-m"
Order by
|
Last updated:
15 January 2026
BB20260116
Members are advised to lodge amendments in good time before the beginning of a Stage and as early as possible during the day. (G) = Government Bill; (M) = Member’s Bill; (C) = Committee Bill; (P) = Private Bill; (H) = Hybrid Bill.
Last updated:
7 March 2023
BB20200121Rev
The supply and demand for medicines inquiry (in private): The Committee will consider the evidence heard earlier in the meeting.
Last updated:
21 November 2022
Paper 2 Written submissions 24 November 2022
However, the Taskforce believes that it would be even more beneficial for naloxone to be reclassified from a ‘Prescription Only Medicine’ to a ‘Pharmacy’ or a ‘General Sales List’ medicine.
Official Report
Meeting date:
10 February 2026
Health, Social Care and Sport Committee 10 February 2026 [Draft]
Yes, I agree that electronic prescribing will help, too, as will optimising medicines management and stewardship, but for me the starting point is ensuring that medicine prescribing is as good as it can be.
Committee reports
Date published:
30 June 2020
Supply and demand for medicines - Shortages
Shortages
Warwick Smith (BGMA) providediHealth and Sport Committee, Official Report, 21 January 2020, Col 28 us with examples of why shortages of medicines occur, such as manufacturing changes abroad and reduced capacity due to adherence to regulatory requirements for packaging.
SPICe briefings
Date published:
20 March 2018
The impact of Brexit on Scotland's growth sectors - Trade
Retrieved from <a href="https://www.parliament.uk/business/committees/committees-a-z/commons-select/health-committee/news-parliament-2017/brexit-medicines-substances-evidence-17-192/" target="_blank">https://www.parliament.uk/business/committees/committees-a-z/commons-select/health-committee/news-parliament-2017/brexit-medicines-substances-evidence-17-192/</a> [accessed 16 March 2018] about the impact of new regulatory processes after Brexit.
SPICe briefings
Date published:
4 November 2024
Assisted Dying for Terminally Ill Adults (Scotland) Bill - Republished - The approach taken in the Bill around legislative competence and the practical consequences for the implementation of the Bill
Use by the UK Government of existing powers
The UK Government could use existing powers under misuse of drugs or medicines legislation to permit the use of certain drugs for the purposes set out in the Bill.
Last updated:
28 January 2025
PE2137_A
The proposal is that certain procedures should be undertaken in a premises regulated by Healthcare Improvement Scotland, that they should be undertaken by a trained practitioner working under the supervision of an appropriate healthcare professional, who would be available to prescribe any prescription only medicines required in the procedure, or support in...
Last updated:
7 March 2023
BB20201001
Members are advised to lodge amendments in good time before the beginning of a Stage and as early as possible during the day. (G) = Government Bill; (M) = Member’s Bill; (C) = Committee Bill; (P) = Private Bill; (H) = Hybrid Bill.
Last updated:
7 March 2023
BB20210225
S5W-35514 David Torrance: To ask the Scottish Government what action it is taking following the Medicines and Healthcare Products Regulatory Agency's (MHRA) review of the use of UK plasma for fractionation.
